secwatch.observer — SEC 8-K summary
======================================

Issuer:     Item 9 Labs Corp. (—)
CIK:        0001500123
Form:       8-K
Filed at:   2023-07-20T23:59:59+00:00
Accession:  0001554795-23-000219
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.03, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Item 9 Labs enters receivership; Chairman/Interim CEO resigns after entity he controls files for receiver
--------------------------------------------------------------------------------

- Receiver Jeremiah Foster (Resolute Commercial) appointed July 14, 2023 by Arizona Superior Court.
- Receiver granted full possession, custody, and control of all company property to maximize value for creditors and equity holders.
- Receiver requested by Viridis Group Holdings and Viridis Group I9 Capital, both controlled by Douglas Bowden (Chairman/Interim CEO) and Andrew Bowden (former CEO).
- Douglas Bowden resigned as Chairman and Interim CEO effective July 18, 2023; positions left vacant due to receivership.
- Court stipulation agreed to by the company; receivership covers all real, personal, tangible, and intangible property.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500123/000155479523000219/0001554795-23-000219-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500123/000155479523000219/inlb0720form8k.htm
  HTML page:      https://secwatch.observer/filing/0001554795-23-000219

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer